Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Doyle

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2011
Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trialD Mark Davies, Petrus J de Vries, Simon R Johnson, et al.
Journal of Medicinal Chemistry|October 16, 2014
Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liabilityAnne-Laure Grillot, Arnaud Le Tiran, Dean Shannon, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2011
Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trialD Mark Davies, Petrus J de Vries, Simon R Johnson, et al.
Journal of Medicinal Chemistry|October 16, 2014
Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liabilityAnne-Laure Grillot, Arnaud Le Tiran, Dean Shannon, et al.
Pageof 3